Hydrocortisone oral solution (Khindivi) was approved as a replacement therapy for pediatric patients ages 5 years and up with ...

CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...

In December, the U.S. Food and Drug Administration (FDA) approved a new treatment for people with insomnia, Dayvigo (lemborexant). The drug will be available in 5 or 10 milligram (mg) doses ...

A medication already prescribed to relieve menopausal symptoms could also help prevent invasive breast cancer. That's the ...

A vegan diet rich in soy reduced severe hot flashes by 92% in postmenopausal women, according to a new study published in ...

Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...

Hot flashes are sudden surges of sweat, sudden heat, or flushed skin. They are a common symptom of menopause. According to J ...

Twinkle Khanna shared an Instagram post in which she mentioned she was getting hot flashes. What is a hot flash and what causes it? Find out.

When the FDA approved fezolinetant for treating moderate to severe hot flashes in menopausal women, the news made headlines.

For women at higher risk of breast cancer, there is a proven way to cut the risk in half: take an anti-cancer drug such as ...

There are estrogen receptors in your breast tissue, which means a drop in estrogen can lead to breast changes, Dr. Streicher ...